VSIG2 Blocking Peptide (C-term)
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q96IQ7 |
---|---|
Other Accession | NP_055127.2 |
Gene ID | 23584 |
---|---|
Other Names | V-set and immunoglobulin domain-containing protein 2, Cortical thymocyte-like protein, CT-like protein, VSIG2, CTH, CTXL |
Target/Specificity | The synthetic peptide sequence is selected from aa 265-278 of HUMAN VSIG2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | VSIG2 |
---|---|
Synonyms | CTH, CTXL |
Cellular Location | Membrane; Single-pass type I membrane protein |
Tissue Location | Highly expressed in stomach, colon, prostate, trachea and thyroid glands and weakly in bladder and lung |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The function of this protein is unknown.
References
Kariuki, S.N., et al. Arthritis Res. Ther. 12 (4), R151 (2010) :
Zhang, Z., et al. Protein Sci. 13(10):2819-2824(2004)
Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)
Chretien, I., et al. Eur. J. Immunol. 28(12):4094-4104(1998)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.